The TRERF1 (Transcriptional Regulating Factor 1) antibody is a tool used to study the TRERF1 protein, a nuclear receptor co-regulator implicated in transcriptional regulation. TRERF1. also known as TBLR1 (Transducin Beta-Like 1X-Linked Receptor 1), interacts with nuclear receptors, including thyroid hormone receptors and retinoid X receptors, modulating their transcriptional activity. It plays roles in diverse biological processes, such as cell differentiation, proliferation, and apoptosis, by serving as a scaffold for chromatin-modifying complexes. TRERF1 antibodies are essential for detecting protein expression, localization, and interaction partners via techniques like Western blotting, immunohistochemistry, and co-immunoprecipitation. Research links TRERF1 dysregulation to cancers, metabolic disorders, and developmental anomalies, highlighting its potential as a therapeutic target. Validated antibodies are crucial for exploring its mechanism in signaling pathways and disease contexts. Most TRERF1 antibodies target specific epitopes, often in the N-terminal or C-terminal regions, and are available in monoclonal or polyclonal forms. Proper validation, including knockout controls, ensures specificity. Studying TRERF1 enhances understanding of nuclear receptor-mediated gene regulation and its pathological implications.